Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Cyclosporine
  • Graft vs Host Disease
  • Hematopoietic Stem Cell Transplantation
  • Immunosuppressive Agents
  • Multiple Myeloma

abstract

  • Induction of autologous GVHD by posttransplant cyclosporine is feasible and well tolerated in patients with multiple myeloma.

publication date

  • February 1997

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 9053492

Additional Document Info

start page

  • 667

end page

  • 73

volume

  • 15

number

  • 2